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ABSTRACT
Essential oils (EOs) extracted from Lavandula luisieri and Cymbopogon 
citratus were tested for their antifungal activity against ten clinical isolates 
of dermatophytes isolated from cases of tinea pedis. Inhibition of conidial 
germination and antifungal drug/EO combination assay were tested 
on two ATCC reference strains of Trichophyton rubrum and Trichophyton 
mentagrophytes. EOs were characterised by high amount of oxygenated 
monoterpenes in their composition. Strong antifungal activity was 
observed for the majority of clinical strains, and fungicidal activity was 
demonstrated. Positive interaction between L. luisieri EO combined with 
terbinafine was observed against terbinafine-resistant strain (Tr ATCC 
MYA-4438). Significative reduction of the germination was observed 
above 100 μg mL−1. Both oils were safe to macrophage mammalian cells 
at tested concentration. This study describes the antifungal activity of  
L. luisieri and C. citratus EOs against dermatophytes, which could be useful 
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1. Introduction
Dermatophytoses are among the most prevalent infectious diseases worldwide, which inci-
dence has increased, mainly on urban environments. Occasionally, it can spread to other 
parts of the body, and it is highly contagious. High rate of recurrence following antifungal 
treatment limited use in some patients due to side effect, and medication interactions are 
common problems found when using conventional drugs (Vander Straten et al. 2003). Thus, 
clinical isolates of drug-resistant Trichophyton rubrum exhibiting high-level primary resistance 
to terbinafine have been reported (Favre et al. 2004). Medicinal plants are the richest natural 
source of bioactive phytochemicals and antioxidants. Among those, monoterpenes are main 
constituents of essential oils (EOs). Furthermore, EOs containing high amounts of oxygenated 
monoterpenes (OM) are related to broad spectrum antibacterial activities (Messaoud et al. 
2012; Ait Said et al. 2015; Carrasco et al. 2016).
In this study, Lavandula luisieri and Cymbopogon citratus, which are known for their high 
content of OM, were tested for their potential use as topical therapeutic agents against 
dermatophyte strains involved in foot dermatophytoses.
2. Results and discussion
2.1. Analysis of oils, antifungal activities and viability assay
Major compounds are listed in Table S1. L. luisieri EO was predominantly composed by oxy-
genated necrodane derivatives, followed by 1,8-cineol as main compounds. The presence 
of necrodane derivatives has been reported as the characteristic and dominant compounds 
in L. luisieri EO, which could be used as a chemotaxonomic marker of this species (Zuzarte 
et al. 2012). Both EOs were characterised by high amounts of oxygen-containing monoter-
penes (OM > 75%) totalizing 80.4% and 97.9% of monoterpenic compounds (MH and OM) 
for L. luisieri and C. citratus, respectively. In Table S2, a strong antifungal activity and a fun-
gicidal mode of action with MFC = 200 μg mL−1 were observed for both EOs. Antifungal 
effect of both EOs was dose dependent for all dermatophytes (Figure S1), although C. citratus 
showed a mild effect on clinical strains of T. mentagrophytes. Strong antifungal activity has 
been positively correlated with the presence of OM (Mesa-Arango et al. 2009; Prusinowska 
et al. 2016). Besides, L. luisieri EO with the highest amount of necrodane compounds shown 
to be the most active against dermatophyte strains (Zuzarte et al. 2012).
2.2. In vitro antifungal drug/EO combination assay
The combination between EOs and conventional antimicrobial drugs has been referred as 
a strategy to bring about the maximum of therapeutic efficacy by additive or synergistic 
effect (Wagner & Ulrich-Merzenich 2009). Although combination therapy has been already 
recommended to improve monotherapy results, few studies (Shin & Lim 2004; Khan & Ahmad 
2011) have reported on the antifungal effect against dermatophytes. Table S3 shows a pos-
itive interaction of L. luisieri EO with terbinafine (TER) against the terbinafine-resistant Tr 
ATCC MYA-4438 in all fixed-ratio concentrations suggesting a synergistic activity between 
the drug and EO, as the effect of the combined substances is greater than the sum of the 
individual effects (Burt 2004). Consequently, a minor dose of terbinafine would be necessary 
to obtain the same antifungal effect when used in combination with L. luisieri EO. In this 
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study, the best antifungal effect was obtained for the ratios 1:1 and 3:1. At TER/EO ratio 1:3, 
combined activity was apparently additive. In this perspective, combined therapy of EO with 
conventional drugs may lead to a reduction of drug doses by decreasing possible adverse 
side effects or increasing therapeutic effects (Khan & Ahmad 2011).
2.3. Effect of EOs on conidial germination and morphology
Both oils proved to be effective in delaying germination of conidia on reference strains. 
Results on the percentage of conidia germinated after 24 h of treatment with L. luisieri and 
C. citratus EOs are displayed in Figure 1. Significant reduction of the germination (p < 0.001) 
was observed for strains treated with EO concentrations above 100 μg mL−1, and most 
conidia were non-germinated at 200 μg mL−1. The effect of L. luisieri EO on the morphology 
of conidia and hyphae after 24 and 48 h of treatment, respectively, is shown in Figure S2. 
 L. luisieri EO induced morphological alterations on T. rubrum conidia. Germination alterations 
were clearly visible after 24 h of exposure at sub-MIC concentrations (A–D). Thus, growth of 
the germinative tube was severely impaired at 50 μg mL−1. At 100 μg mL−1, alterations on 
the morphology of conidia were clearly observed. After 48 h of incubation (E–H), the myce-
lium structure became irregular with the loss of ramifications. No mycelium growth was 
observed for most cells, at 200 μg mL−1. Inhibition of DNA synthesis or disruption of mem-
branes is mechanism of phytotoxicity found in OM, which lead to anatomical and physio-
logical changes (De Martino et al. 2010). Therefore, it was expected that impaired germ tubes 
originated distorted hyphae compromising cell morphogenesis and further growth. In a 
previous work, Zuzarte et al. (2012) reported on the capacity of inhibition of the germ tube 
of Candida albicans by L. luisieri at sub-MIC values.
2.4. Cytotoxicity of EOs
Careful use of lavender oil in highly diluted forms, when applied to the skin, has been rec-
ommended by Prashar et al. (2004). In our study, EOs did not cause a significant alteration 
Figure 1.  effect of L. luisieri and C. citratus on the germination of conidia of reference strains of 
dermatophytes T. rubrum atcc MYa-4438 (a) and T. mentagrophytes atcc MYa-4439 (b). Fungal cultures 
were treated for 24 h with different concentrations of the oils ranging from 0 to 200 μg ml−1. results are 
expressed as percentage of germinated conidia on untreated and treated cultures of dermatophytes. 
Values are expressed as mean  ±  seM from three independent experiments. ***p  <  0.001 significant 
statistical differences compared to control culture. n.s. = not significative.
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on the viability of treated mouse macrophage cells when compared to control cells (Figure 
S3). No induction of alterations on the morphology of cells was observed under light micros-
copy (data not shown). In addition, a very low detrimental effect was found on mouse mac-
rophage cells at concentrations of L. luisieri EO up to 320 μg mL−1 (Zuzarte et al. 2012).
3. Conclusion
The chemical composition of the tested EOs, mainly the OM fraction, suggests an association 
with the activity profile of EOs against dermatophytes. In addition to fungistatic and fungi-
cidal activity, the EOs revealed an important inhibitory effect on germination of conidia at 
sub-MIC concentrations, thus reinforcing their potential use in topical therapy. This study 
also proposes L. luisieri as a suitable oil for combined treatment against terbinafine-resistant 
fungal strains, although further in vivo experiments are needed to evaluate the therapeutic 
efficacy and safety of the EO in combination with antifungal drugs.
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